Beta globin gene (HBB) sequencing can be used to identify hemoglobin variants and the most common beta thalassemia mutations, including beta plus and beta zero thalassemias. It also identifies hyperunstable hemoglobin variants and dominant beta thalassemia mutations, as well as other hemoglobin variants that cannot be identified by protein methods.